‘At war time speed’, China leads COVID-19 vaccine race
Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CDSCO asks drug controllers to take measures against black marketing of remdesivir
Reportedly, the drug is being sold at exorbitant prices ranging between Rs 15,000 to Rs 60,000
J&J drops TB drug price following mass petition
Médecins Sans Frontières insisted that prices should come further down from the revised price of the drug, bedaquiline, hailed as…
EMA launches public consultation on joint network strategy to 2025
Inputs can be submitted until September 4 via an online questionnaire
Sovereign Pharma releases first batch of remdesivir to Cipla
Cipla is likely to launch Cipremi in two to three days
Lipidor and Cadila Pharma strike partnership for psoriasis drug candidate’s phase III clinical…
The Phase III study is expected to involve 270 patients and will be conducted in India on patients with various skin types
Dept of Consumer Affairs withdraws masks, hand sanitisers from Essential Commodities Act
Public health activists raise concerns about the move and demand that the decision should be reconsidered
Caplin Steriles signs distribution agreement with Xellia Pharmaceuticals
The former to license five of its injectable ANDAs to Xellia Pharmaceuticals for commercialisation in the US
X-ray structure analysis gives detailed insights into bacterial molecular factory
A team of the Technical University of Munich (TUM) and the Goethe University Frankfurt has now succeeded in investigating the…
CureVac nets EU funding to ramp up vaccine production
CureVac, backed by the Bill & Melinda Gates Foundation, is a pioneer in the so-called messenger RNA approach, which is also…